Contact

The information we have provided here is not exhaustive and is aimed as a practical tool for aid in the management of patients with MDR-TB. A list of references is included in a separate document however the majority of these recommendations are based on expert consensus. Feedback is welcomed. This is a drug monitoring guideline, for treatment guidance please refer to the WHO Consolidated Guidelines on Tuberculosis, Module 4: Treatment - Drug-Resistant Tuberculosis Treatment https://www.who.int/publications/i/item/9789240007048 and the BTS MDR-TB Clinical Advisory Service www.brit-thoracic.org.uk/quality-improvement/lung-disease-registries/bts-mdr-tb-clinical-advice-service/